We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12B
AUM Growth
-$882M
Cap. Flow
-$307M
Cap. Flow %
-2.56%
Top 10 Hldgs %
23.8%
Holding
2,895
New
41
Increased
683
Reduced
1,007
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 13.65%
3 Financials 12.21%
4 Consumer Discretionary 10.98%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBMS
2001
DELISTED
The First Bancshares, Inc.
FBMS
$307K ﹤0.01%
10,279
MORN icon
2002
Morningstar
MORN
$7.76B
$307K ﹤0.01%
1,446
NAPA
2003
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$307K ﹤0.01%
21,275
TR icon
2004
Tootsie Roll Industries
TR
$3.02B
$307K ﹤0.01%
10,382
+2,142
+26% +$66.9K
GCO icon
2005
Genesco
GCO
$394M
$307K ﹤0.01%
7,807
VTOL icon
2006
Bristow Group
VTOL
$1.38B
$306K ﹤0.01%
13,043
TRNS icon
2007
Transcat
TRNS
$888M
$306K ﹤0.01%
4,039
LAND
2008
Gladstone Land Corp
LAND
$358M
$305K ﹤0.01%
16,827
DKNG icon
2009
DraftKings
DKNG
$12.6B
$304K ﹤0.01%
20,097
-3,397
-14% -$54K
FPI
2010
Farmland Partners
FPI
$425M
$304K ﹤0.01%
24,006
NKTR icon
2011
Nektar Therapeutics
NKTR
$2.57B
$304K ﹤0.01%
6,336
OSW icon
2012
OneSpaWorld
OSW
$2.73B
$304K ﹤0.01%
36,131
+6,652
+23% +$55.8K
NRIX icon
2013
Nurix Therapeutics
NRIX
$2.82B
$303K ﹤0.01%
23,288
RPRX icon
2014
Royalty Pharma
RPRX
$26.1B
$303K ﹤0.01%
7,550
-183
-2% -$7.82K
EGLE
2015
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$303K ﹤0.01%
7,016
INGN icon
2016
Inogen
INGN
$154M
$303K ﹤0.01%
12,466
+1,255
+11% +$34.6K
ORGN
2017
DELISTED
Origin Materials
ORGN
$303K ﹤0.01%
1,955
VNDA icon
2018
Vanda Pharmaceuticals
VNDA
$304M
$302K ﹤0.01%
30,601
NVTA
2019
DELISTED
Invitae Corporation
NVTA
$302K ﹤0.01%
122,893
+30,807
+33% +$93.5K
AVD icon
2020
American Vanguard Corp
AVD
$62.8M
$302K ﹤0.01%
16,147
TSVT
2021
DELISTED
2seventy bio
TSVT
$301K ﹤0.01%
20,718
FMBH icon
2022
First Mid Bancshares
FMBH
$1.39B
$301K ﹤0.01%
9,423
ALEC icon
2023
Alector
ALEC
$228M
$301K ﹤0.01%
31,825
CNDT icon
2024
Conduent
CNDT
$252M
$300K ﹤0.01%
89,918
+14,539
+19% +$60.7K
STER
2025
DELISTED
Sterling Check Corp. Common Stock
STER
$300K ﹤0.01%
17,023
+5,701
+50% +$113K

Similar funds

MetLife Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, MetLife Investment Management held 2,895 positions worth $12B, down 6.8% from $12.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. MetLife Investment Management opened 41 new positions and exited 96, leaving the 2,895-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q3 2022 buy was Aspen Technology Inc: 19,662 shares worth $4.68M.
  • MetLife Investment Management added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $24.5M increase.
  • MetLife Investment Management's biggest Q3 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $138M.
  • MetLife Investment Management fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.77M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12B portfolio in Q3 2022.
  • MetLife Investment Management opened 41 new positions and closed 96 in Q3 2022.
  • MetLife Investment Management's portfolio value fell 6.8% quarter-over-quarter to $12B.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.